Clinical Trial Detail

NCT ID NCT03184870
Title A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

pancreatic cancer

colorectal cancer

Therapies

BMS-813160 + Fluorouracil + Irinotecan + Leucovorin

BMS-813160 + Nivolumab

BMS-813160 + Gemcitabine + Nab-paclitaxel

BMS-813160

Age Groups: adult senior

No variant requirements are available.